ContraFect

YTD

ALL

Why Robinhood?

You can watch ContraFect and buy or sell other stocks, ETFs, and their options commission-free!

About CFRX

ContraFect Corp. is a clinical stage biotechnology company, which engages in the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medical modalities for the treatment of life-threatening, antibiotic-resistant infections. Its product pipeline consists of CF-301, Gram-Negative Lysins, and Amurin Peptides.

CEO

Michael Messinger, CPA

CEOMichael Messinger, CPA

Employees

—

Employees—

Headquarters

Yonkers, New York

HeadquartersYonkers, New York

Founded

2008

Founded2008

Employees

—

Employees—

CFRX Key Statistics

Market cap

1.10K

Market cap1.10K

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

3.00

Average volume3.00

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$0.14

52 Week high$0.14

52 Week low

—

52 Week low—

Stock Snapshot

As of today, ContraFect(CFRX) shares are valued at $2.24. The company's market cap stands at 1.1K.

During the trading day, ContraFect(CFRX) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 3.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.